Cargando…
Antibodies binding diverse pertactin epitopes protect mice from Bordetella pertussis infection
Infection by the bacterium Bordetella pertussis continues to cause considerable morbidity and mortality worldwide. Many current acellular pertussis vaccines include the antigen pertactin, which has presumptive adhesive and immunomodulatory activities, but is rapidly lost from clinical isolates after...
Autores principales: | Silva, Rui P., DiVenere, Andrea M., Amengor, Dzifa, Maynard, Jennifer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931430/ https://www.ncbi.nlm.nih.gov/pubmed/35151691 http://dx.doi.org/10.1016/j.jbc.2022.101715 |
Ejemplares similares
-
Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis
por: DiVenere, Andrea M., et al.
Publicado: (2022) -
Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin
por: Williams, Margaret M., et al.
Publicado: (2016) -
Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986–2018
por: Mir-Cros, Alba, et al.
Publicado: (2022) -
Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
por: Ma, Longhuan, et al.
Publicado: (2021) -
Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan
por: Otsuka, Nao, et al.
Publicado: (2012)